US 9101643
Lipid formulated compositions and methods for inhibiting expression of transthyretin (TTR)
granted A61KA61K31/7088A61K31/7115
Quick answer
US patent 9101643 (Lipid formulated compositions and methods for inhibiting expression of transthyretin (TTR)) held by Alnylam Pharmaceuticals, Inc. expires Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Aug 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K31/7088, A61K31/7115, A61K31/713, A61P